Simplex Trading’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-3,543
| Closed | -$49K | – | 9536 |
|
|
2025
Q2 | $40K | Buy |
+3,543
| New | +$43.3K | ﹤0.01% | 6144 |
|
|
2025
Q1 | – | Sell |
-35,125
| Closed | -$358K | – | 9065 |
|
|
2024
Q4 | $297K | Buy |
35,125
+33,041
| +1,585% | +$342K | ﹤0.01% | 4073 |
|
|
2024
Q3 | $24K | Buy |
2,084
+869
| +72% | +$10.9K | ﹤0.01% | 6529 |
|
|
2024
Q2 | $14K | Sell |
1,215
-2,211
| -65% | -$25.8K | ﹤0.01% | 7186 |
|
|
2024
Q1 | $40K | Buy |
+3,426
| New | +$45.7K | ﹤0.01% | 6471 |
|
|
2023
Q4 | – | Sell |
-8,810
| Closed | -$80.2K | – | 9328 |
|
|
2023
Q3 | $84K | Buy |
8,810
+7,520
| +583% | +$76.8K | ﹤0.01% | 5267 |
|
|
2023
Q2 | $11K | Buy |
1,290
+194
| +18% | +$1.79K | ﹤0.01% | 7317 |
|
|
2023
Q1 | $8K | Buy |
+1,096
| New | +$8.18K | ﹤0.01% | 7725 |
|
|
2022
Q3 | – | Sell |
-577
| Closed | -$8.06K | – | 10397 |
|
|
2022
Q2 | $5K | Buy |
577
+511
| +774% | +$5.64K | ﹤0.01% | 8832 |
|
|
2022
Q1 | $0 | Buy |
+66
| New | +$948 | ﹤0.01% | 10912 |
|
|
2021
Q4 | – | Sell |
-3,623
| Closed | -$88K | – | 10934 |
|
|
2021
Q3 | $88K | Hold |
3,623
| – | – | ﹤0.01% | 6802 |
|
|
2021
Q2 | $86K | Buy |
3,623
+2,376
| +191% | +$62.2K | ﹤0.01% | 6944 |
|
|
2021
Q1 | $32K | Sell |
1,247
-6,323
| -84% | -$166K | ﹤0.01% | 7064 |
|
|
2020
Q4 | $143K | Buy |
+7,570
| New | +$130K | ﹤0.01% | 5040 |
|
Other funds holding KALV
Simplex Trading's KALV Position: Q3 2025 in Review
Simplex Trading sold out of KalVista Pharmaceuticals (KALV) in Q3 2025, closing a stake of 3,543 shares — an estimated $49K sold.
Simplex Trading first reported a position in KALV in Q4 2020 and held it in 14 quarters. The position peaked at $297K in Q4 2024. 145 funds tracked by Wall St. Rank hold KALV as of Q3 2025.
- Simplex Trading reported no remaining KalVista Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
- Simplex Trading sold 3,543 KalVista Pharmaceuticals shares in Q3 2025, an estimated $49K.
- Simplex Trading first reported a position in KalVista Pharmaceuticals in Q4 2020 and held it in 14 quarters.
- Simplex Trading's KalVista Pharmaceuticals position peaked at $297K in Q4 2024.
- 145 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q3 2025.
Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.